1 documents found
Information × Registration Number 0203U006016, 0101U008314 , R & D reports Title The development of method of antirelapse treatment drug addicted patients based on the long acting opiate receptors blockers. popup.stage_title Head Linsky I.V., Доктор медичних наук Registration Date 03-02-2003 Organization Ukrainian SRI of Clinical and Experimental Neurology and Psychiatry popup.description2 The aim this work is creation of the method of antirelapse treatment of opiate addicted patients. The preclinical testaments of new long-acting opioblockers - naloxone- prolong were carried out. It was established that the naloxone-prolong belongs to nontoxic substances (V class of toxicity). The revealed adverse effects of naloxone-prolong is cause, mainly, by solvents. It was proposed to continue testament of naloxone-prolong, as a base for antirelapse treatment of opiate addiction, after replace of ethyloleate by nontoxic solvents. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
1
Head: Linsky I.V.. The development of method of antirelapse treatment drug addicted patients based on the long acting opiate receptors blockers.. (popup.stage: ). Ukrainian SRI of Clinical and Experimental Neurology and Psychiatry. № 0203U006016
1 documents found

Updated: 2026-03-24